LI
TDOC icon

Leap Investments’s Teladoc Health TDOC Stock Holding History

Leap Investments’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$859K Buy
+4,500
New +$789K 0.57% 33

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Leap Investments's TDOC Position: Q2 2020 in Review

Leap Investments opened a new position in Teladoc Health (TDOC) in Q2 2020: 4,500 shares worth $859K. The stake represents 0.57% of the portfolio and ranks #33 among its holdings.

670 funds tracked by Wall St. Rank hold TDOC as of Q2 2020.

  • Leap Investments held 4,500 shares of Teladoc Health worth $859K as of Q2 2020.
  • Teladoc Health was a new Leap Investments position in Q2 2020.
  • Teladoc Health made up 0.57% of Leap Investments's portfolio in Q2 2020, its #33 holding.
  • 670 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.